Accepted for Publication: December 23, 2021.
Published: February 15, 2022. doi:10.1001/jamanetworkopen.2021.48581
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2022 Zhou JZ et al. JAMA Network Open.
Corresponding Author: Jade Zifei Zhou, MD, PhD, Moores Cancer Center at University of California San Diego Health, 3855 Health Sciences Dr, MC 0829, La Jolla, CA 92093-0829 (jzzhou@health.ucsd.edu).
Author Contributions: Drs Gold and Zhou had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Gold.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Zhou, Ramsey, Gold.
Critical revision of the manuscript for important intellectual content: Zhou, Kane, Akhondzadeh, Banerjee, Shatsky, Gold.
Statistical analysis: Shatsky, Gold.
Administrative, technical, or material support: Kane, Ramsey, Akhondzadeh, Gold.
Supervision: Shatsky, Gold.
Conflict of Interest Disclosures: Dr Gold reported receiving personal fees from AstraZeneca; personal fees from Takeda, Rakuten, and Regeneron; and grants from Pfizer and Pharmacyclics outside the submitted work. No other disclosures were reported.
Additional Contributions: We thank Jing Zhang, MSc (Moores Cancer Center, University of California San Diego Health), for assistance with statistical analysis. There was no financial compensation for this contribution.
1.Nelson
HD , Fu
R , Cantor
A , Pappas
M , Daeges
M , Humphrey
L . Effectiveness of breast cancer screening: systematic review and meta-analysis to update the 2009 U.S. Preventive Services Task Force recommendation.
Ann Intern Med. 2016;164(4):244-255. doi:
10.7326/M15-0969
PubMedGoogle ScholarCrossref